Abstract:Alzheimer's disease (AD) is the major cause of dementia. During the development of AD, neurofibrillary tangles progress in a fixed pattern, starting in the transentorhinal cortex followed by the hippocampus and cortical areas. In contrast, the deposition of β-amyloid (Aβ) plaques, which are the other histological hallmark of AD, does not follow the same strict spatiotemporal pattern, and it correlates poorly with cognitive decline. Instead, soluble Aβ oligomers have received increasing attention as probable inducers of pathogenesis. In this study, we use microinjections into electrophysiologically defined primary hippocampal rat neurons to demonstrate the direct neuron-to-neuron transfer of soluble oligomeric Aβ. Additional studies conducted in a human donor-acceptor cell model show that this Aβ transfer depends on direct cellular connections. As the transferred oligomers accumulate, acceptor cells gradually show beading of tubulin, a sign of neurite damage, and gradual endosomal leakage, a sign of cytotoxicity. These observations support that intracellular Aβ oligomers play a role in neurodegeneration, and they explain the manner in which Aβ can drive disease progression, even if the extracellular plaque load is poorly correlated with the degree of cognitive decline. Understanding this phenomenon sheds light on the pathophysiological mechanism of AD progression. Additional elucidation will help uncover the detailed mechanisms responsible for the manner in which AD progresses via anatomical connections and will facilitate the development of new strategies for stopping the progression of this incapacitating disease.

Neuron-to-Neuron Transmission of Neurodegenerative Pathology

Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-amyloid

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Cell-to-cell Transmission of Pathogenic Proteins in Neurodegenerative Diseases

Spreading of pathology in neurodegenerative diseases: a focus on human studies

Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

Protein transmission in neurodegenerative disease

Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases

Insights into the Neurodegenerative Process of Alzheimer's Disease: a Role for Mononuclear Phagocyte-Associated Inflammation and Neurotoxicity

A network aggregation model for the dynamics and treatment of neurodegenerative diseases at the brain scale

Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation

A review of proposed mechanisms for neurodegenerative disease

Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome

Targeting Prion-Like Protein Spreading in Neurodegenerative Diseases

Revisit the Cellular Transmission and Emerging Techniques in Understanding the Mechanisms of Proteinopathies

Alzheimer's disease.

Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View

Potential Modes of Intercellular α-Synuclein Transmission

A Multiscale Closed-Loop Neurotoxicity Model of Alzheimer's Disease Progression Explains Functional Connectivity Alterations

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

Nonlocal models in the analysis of brain neurodegenerative protein dynamics with application to Alzheimer's disease